Related Experiment Videos

The benefit/risk ratio of low dose cyclosporin A in rheumatoid arthritis

R M Flipo¹, O Reigneau

¹Hôpital B, CHRU Lille, France.

The Journal of Rheumatology

|February 1, 1996

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Real-World Experience and Impact of Canakinumab in Cryopyrin-Associated Periodic Syndrome: Results From a French Observational Study.

Arthritis care & research·2016

Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry.

Annals of the rheumatic diseases·2015

Identification of patients with gout: elaboration of a questionnaire for epidemiological studies.

Annals of the rheumatic diseases·2014

Comparison of patient satisfaction with two different etanercept delivery systems. A randomised controlled study in patients with rheumatoid arthritis.

Zeitschrift fur Rheumatologie·2012

Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registry.

Annals of the rheumatic diseases·2012

Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis.

Annals of the rheumatic diseases·2011

See all related articles